Newsroom

News

The Helmholtz Institute for One Health (HIOH) was ceremoniously founded on 26 April 2022 in Greifswald. The HIOH is a new institute of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, which is being established together with the University of Greifswald, the Greifswald University Medicine and the Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health (FLI) as local founding partners. The founding director is the veterinarian and microbiologist Prof Fabian Leendertz. Research at the new institute will focus on the threats posed by the emergence of pathogens, as well as the epidemiology and ecology of antimicrobial resistance (AMR) to common medicines and vaccines.

26.04.2022

HIOH

A black mouse is held by a person wearing blue laboratory gloves.

Story

The Helmholtz Centre for Infection Research has set itself the goal of finding new diagnostic methods, new active substances and new therapies against infectious diseases. Here you can find out why we cannot forgo animal experiments in our research.

24.04.2022

HZI Campus

TWINCORE

HIPS

News

The human gut is colonized by countless microorganisms. Could some of them protect humans from infections? Principal Investigator Alexander Westermann aims to better understand the interaction between host cells, gut bacteria and pathogens. He now receives funding of 1.5 million euros for his research project “GUT-CHECK” from the European Research Council (ERC). Westermann is the fourth group leader at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg to be awarded an ERC grant.

29.03.2022

HIRI

News

Though it has been eclipsed lately by SARS-CoV-2, there is another global epidemic still threatening people: HIV/AIDS. According to UNAIDS, a United Nations initiative, some 38 million people worldwide are currently infected with HIV. Almost as many have died as a result of AIDS since the outbreak of the HIV pandemic in the 1980s. In the search for new approaches to antiviral therapies, scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the Robert Koch Institute (RKI) in Berlin have now developed a new technology that can be used to analyze and impact key stages of the HIV life cycle. Their findings were published today in the journal Nature Structural and Molecular Biology.

28.03.2022

HIRI

News

The bacterium Escherichia coli is found in the human intestine, and elsewhere. There it is harmless, but in certain conditions it can become a pathogen. It can cause bladder infections or even sepsis. A team of researchers led by RESIST professor Marco Galardini at TWINCORE - Centre for Experimental and Clinical Infection Research, a joint facility of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Hannover Medical School (MHH), together with colleagues from the medical faculty of the University of Paris, has now investigated whether certain genes of the bacterium are associated with the severity of the diseases caused. They have now published their findings in the journal PLOS Genetics.

24.03.2022

TWINCORE

News

What tasks need to be done today, and which is the most urgent? People have to constantly set priorities in their daily life. Bacteria are no different: They too must prioritize when combating viruses with CRISPR. However, it was unclear how this prioritization takes place. Scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, a joint venture of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Julius Maximilian University (JMU) Würzburg, in cooperation with researchers from the universities of Würzburg, Freiburg and Leipzig, have now described an underlying mechanism for the first time. Their study was published in the journal Nature Microbiology.

21.03.2022

HIRI

Back to the first page
...
43
44
45
46
...
148

HZI in the media

Quelle: Pressemitteilung

HZI-Helmholtz Zentrum für Infektionsforschung ...

04.11.2025

LaborPraxis

Forschende des Helmholtz-Zentrums für Infektionsforschung und der Universität Würzburg entwickeln derzeit einen Kaugummi, der Grippeviren

04.11.2025

Arbeitsmedizin-Sozialmedizin-Umweltmedizin

... Vakzinologie und angewandte Mikrobiologie am Helmholtz-Zentrum für Infektionsforschung. Die M2-Membranproteinhemmer verhindern ...

02.11.2025

Augsburger Allgemeine

... etwas dran ist“, erklärt Biologe Marc Stadler vom Helmholtz-Zentrum für Infektionsforschung gegenüber der Barmer-Krankenkasse. „Es ...

30.10.2025

bild der wissenschaft

could be reintroduced at any time. Epidemiologists at the Helmholtz Center for Infection Research (HZI) have now shown that many people do

23.10.2025

MSN.com

... eingeschleppt werden könnte. Epidemiolog:innen des Helmholtz-Zentrums für Infektionsforschung (HZI) haben nun gezeigt, dass ...

23.10.2025

innovations report

this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss

22.10.2025

Phys.org

Malaria-Medikamentes ermöglichen könnte. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung in Zusammenarbeit mit ...

22.10.2025

Verband Deutscher Biologen e.V.

(Bild: DOI: 10.1021/jacs.5c08354 / Hips / CC BY 4.0) Wissenschaftler am Hips entwickelten eine Plattform zur Produktion von Furanoliden, die effektiv gegen Bakterien und Krebszellen wirken können und vielversprechende Wirkstoffe darstellen.

21.10.2025

PROCESS

at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in partnership with the Helmholtz Centre for Infection Research (HZI

20.10.2025

Bioengineer.org

their biological activity. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

20.10.2025

Phys.org

... die Abteilung „Experimentelle Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig, lehrt als Professor an ...

17.10.2025

Deutsches Ärzteblatt

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.